(2-R*,5-S*,10-S*)-6,10-DIMETHYL-2-[(1-METHYL-1-BETA-D-FUCOPYRANOSYLOXY)-ETHYL]-SPIRO-[4.5]-DEC-6-EN-8-ONE
Compound with spectra: 1 NMR
![(2-R*,5-S*,10-S*)-6,10-DIMETHYL-2-[(1-METHYL-1-BETA-D-FUCOPYRANOSYLOXY)-ETHYL]-SPIRO-[4.5]-DEC-6-EN-8-ONE](/api/compound/5XY4qA5CVZa.png?ph=true&h=300&w=458 "(2-R*,5-S*,10-S*)-6,10-DIMETHYL-2-[(1-METHYL-1-BETA-D-FUCOPYRANOSYLOXY)-ETHYL]-SPIRO-[4.5]-DEC-6-EN-8-ONE")
| SpectraBase Compound ID | 5XY4qA5CVZa |
|---|---|
| InChI | InChI=1S/C21H34O6/c1-11-8-15(22)9-12(2)21(11)7-6-14(10-21)20(4,5)27-19-18(25)17(24)16(23)13(3)26-19/h8,12-14,16-19,23-25H,6-7,9-10H2,1-5H3/t12-,13-,14+,16+,17+,18-,19+,21-/m0/s1 |
| InChIKey | NZKKTOYUJIISMI-DIWNAUDMSA-N |
| Mol Weight | 382.5 g/mol |
| Molecular Formula | C21H34O6 |
| Exact Mass | 382.235539 g/mol |
| Enantiomer InChIKey | NZKKTOYUJIISMI-YGSVYAAPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3CN |
(2-R*,5-S*,10-S*)-10-METHYL-6-METHYLENE-2-[(1-METHYL-1-BETA-D-FUCOPYRANOSYLOXY)-ETHYL]-SPIRO-[4.5]-DECAN-8-ONE
(2-R*,5-S*,7-S*,10-S*)-10-METHYL-2-[(1-METHYL-1-BETA-D-FUCOPYRANOSYL6-METHYLENESPIRO-[4.5]-DECAN-7-OL
(5R,7R,10S)-ISOPTEROCARPOLONE-BETA-D-GLUCOPYRANOSIDE;(5R,7R,10S)-11-HYDROXY-EUDESM-3-EN-2-ONE-11-O-BETA-D-GLUCOPYRANOSIDE
PTERODONTOSIDE-A;2-ALPHA,4-BETA-DIHYDROXY-11-(BETA-D-GLUCOPYRANOSYLOXY)-ENANTIO-EUDESMANE
7-EPI-GAMMA-EUDESMOL-2'-O-ACETYL-BETA-D-FUCOPYRANOSIDE
(1R,7S,10S)-11-O-BETA-D-GLUCOPYRANOSYL-4-GUAIEN-3-ONE
(S)-7-O-METHYLPEUCEDANOL-3'-O-BETA-D-GLUCOPYRANOSIDE
VOMIFOLIOL-9-O-BETA-D-APIOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
VOMIFOLIOL_3'-O-BETA-APIOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
NICOTABADIOLCOSIDE;1,2-DEHYDRO-4-EPIEREMOPHIL-9-ENE-11,12-DIOL-12-O-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| From Retrospective Assessment to Prospective Decisions in Natural Product Isolation: HPLC-SPE-NMR Analysis of Carthamus oxyacantha | Journal of Natural Products | 2011 |